Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Peck, Peck, Peck,.... Down A Penny A Day...

Trust me I would love nothing more than to find some juicy little nuggets in the 10K that offer reasonable optimism. We all know the PTO is the end game, I don't think anyone would argue with that. A negative outcome would in theory not be a death sentence but, it would set this company back infinitely. The problem with tomorrow #'s being low is the precedent, IMO, that is being set with the valuation of the MMP. I remember several posters lamenting the "watershed" moment of the RIMM signing and also petitioning that the value of the Direct TV license could be much larger than expected. If the end result is substantially lower earnings than hoped for, one has to start asking why these companies are being signed if a PTO re-validation will offer opportunity for much larger license values? I want the numbers to be strong otherwise, it's becoming very difficult to understand the strategy at play. We know both companies have burn rates so are the signing literally to keep TPL flush with cash? If not, then why are licenses issued at lower rates before the PTO ruling? These are just questions on my mind. Hopefully tomorrow will fill in some of the blanks. GLT Everyone, we need it.

Share
New Message
Please login to post a reply